Ellen Nathanson
Nurse Practitioner · Philadelphia, PANPI 1417398777
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Viiv Healthcare Company at 34.4% of the total. Reporting peaked in 2023 at $1,850 and has fallen 82.6% since, to $322 in 2024. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$741
- Merck$467
- Johnson & Johnson$346
- Napo Pharmaceuticals Inc$247
- Janssen Products, LP$100
- plus $339 from 11 others
What the payments were for
- Food & beverage$3,31297%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 69 | $1,173 |
| Gilead | 35 | $741 |
| Merck | 18 | $467 |
| Johnson & Johnson | 18 | $346 |
| Napo Pharmaceuticals Inc | 19 | $247 |
| Janssen Products, LP | 1 | $100 |
| Organon | 3 | $80 |
| Theratechnologies Inc. | 3 | $71 |
| Novo Nordisk | 2 | $36 |
| AbbVie | 1 | $26 |
| Bayer | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| VBI Vaccine (delaware) Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Amgen | 1 | $16 |
How this compares
$3,412 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 49 | $210,548 |
| DescovyEmtricitabine/Tenofov Alafenam | 14 | $30,895 |
| PrezcobixDarunavir/Cobicistat | 12 | $29,708 |
| Estradiol | 13 | $379 |
| ProgesteroneProgesterone, Micronized | 11 | $305 |
| Levocetirizine Dihydrochloride | 11 | $115 |
| Atorvastatin Calcium | 11 | $96 |
| Rosuvastatin Calcium | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $741 | $241,44463 claims |
| Johnson & JohnsonPrezcobix | $346 | $29,70812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Philadelphia
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Carolyn GrandePhiladelphia$71K
- Faith MutalePhiladelphia$62K
- Frances RogersPhiladelphia$46K
- Meghan GarabedianPhiladelphia$30K
- Victoria SherryPhiladelphia$10K
- Tracey WileyChambersburg$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.